Biostimulants: Why a USD 13.5 Billion Market Is Moving Into Mainstream Crop Plans
Updated: 4 days ago
Executive summary. For most of the last two decades, biostimulants sat at the edge of the farm input budget: products that growers tried on high-value fruit and vegetables, often without clear proof of return. That is changing. Climate stress, tighter rules on synthetic inputs and the push for higher yields per hectare are moving seaweed extracts, humic acids and microbial products into mainstream crop programmes. Strategic Revenue Insights estimates the global biostimulants market at USD 4.5 billion in 2025, rising to USD 13.5 billion by 2034 at a 13.00 percent compound annual growth rate. This article sets out five lessons from the input companies, distributors and growers moving first, with takeaways for strategy, product, operations, channels and revenue.
The shape of the market shows where value is building. Strategic Revenue Insights' Biostimulants Market research finds that humic and fulvic acids are the largest product type while microbial biostimulants are the fastest growing, that liquid formulations and foliar application are the most widely used form and method, and that fruits and vegetables are the largest crop segment. Asia Pacific is the fastest growing region. The research names demand for sustainable agricultural practices, the need to protect crop productivity amid climate change, growing farmer acceptance and government initiatives as the main drivers, and lists Syngenta (Valagro), UPL, Novonesis, Corteva Agriscience, Yara International, Haifa Group, Biolchim, Tradecorp (Rovensa), Acadian Plant Health and Isagro (Gowan) among the leading companies.
The largest crop input companies are building biological platforms through acquisition and partnership. Corteva completed its purchase of New Zealand biological crop protection company Biotelliga Holdings for USD 66 million on 1 June 2026, according to its filings with the US Securities and Exchange Commission, adding to the biologicals business it built through earlier deals. Syngenta, which owns biostimulant specialist Valagro, has continued to expand its biologicals research and partnerships. On the regulatory side, the European Union's Fertilising Products Regulation has allowed CE-marked biostimulants to be sold across the single market since July 2022, while in the United States the Plant Biostimulant Act was introduced in the Senate in May 2025 to create a federal definition.
Why the Biostimulants Market Is Entering a New Phase
Three structural forces are converging.
Climate stress has become a yield problem every season. Heat, drought and erratic rainfall now affect yields in most major growing regions. Biostimulants that help plants tolerate abiotic stress, which SRI's research describes as a major focus area, give growers a tool for a problem that fertiliser and crop protection alone do not solve.
Rules on synthetic inputs are tightening. Limits on nitrogen losses, pesticide reduction targets and retailer residue standards push growers toward inputs that improve nutrient use efficiency. Biostimulants that help crops take up more of the fertiliser applied fit directly into that brief.
Regulation is giving the category a clearer identity. The EU's harmonised framework lets a product approved once reach every member state, and the US bill aims to separate biostimulants from plant regulators under pesticide law. Clearer rules make it easier to prove claims, register products and win distributor confidence, although SRI's research still lists the lack of standardised regulation as a key challenge.
These forces explain SRI's forecast of double-digit growth to 2034, with value concentrating in microbial products, stress tolerance and Asia Pacific.
Five Lessons From the Companies Moving First
The companies turning these forces into advantage share a recognisable pattern. We have distilled it into five lessons, each followed by a takeaway for a specific leadership function.
Lesson 1: Sell Measured Return, Not Plant Health Promises
The biggest barrier to biostimulant adoption has never been price alone. It has been proof. Growers who see an extra input line on their budget want to know what it returns per hectare, on their crop, in their conditions. SRI's research lists limited farmer awareness of proper application and benefits as a challenge.
The companies moving first run large networks of replicated field trials, publish yield and quality results by crop and region, and increasingly offer agronomic support that ties product use to measurable outcomes. Some link biostimulant programmes to the soil and yield data growers already collect, which turns a vague promise into a number on a farm management screen.
The same shift from input sales to measured outcomes is shaping digital agriculture, as described in why precision is becoming the only profitable acre in smart farming.
"Growers do not buy plant health. They buy an extra tonne per hectare they can see at harvest."
Takeaway on strategy. Build the commercial case on replicated, crop-specific trial data and measurable return per hectare. Treat agronomic proof as a core asset, not a marketing cost.
Lesson 2: Microbials Are Where the Science Is Moving
SRI's research identifies humic and fulvic acids as the largest product type and microbial biostimulants as the fastest growing. Microbial products, including nitrogen-fixing bacteria, phosphate solubilisers and mycorrhizal fungi, can deliver functions that extracts cannot, such as supplying part of a crop's nitrogen need.
That is why the large crop input companies are buying and partnering for microbial technology. Microbial products are harder to formulate and store, and they need strain libraries, fermentation capacity and quality control. The companies moving first combine strain discovery with formulation science so that living products survive in the tank and in the field.
Takeaway on product. Invest in microbial pipelines through strain libraries, fermentation and formulation science, and position extracts and microbials as complementary products in one crop programme.
Lesson 3: Fit Into the Way Farmers Already Apply Inputs
SRI's research identifies liquid formulations and foliar application as the most widely used form and method, with seed treatment and fertigation growing. Products that fit existing equipment and timings win faster than products that need a new pass across the field.
The companies moving first design biostimulants to tank-mix with fertilisers and crop protection, to coat seed alongside other treatments, and to run through drip and pivot irrigation. Seed treatment is especially attractive: it reaches large row-crop acreage at low cost per hectare and brings the product into seed company channels. Spray drones and variable-rate equipment add another route, as covered in how agricultural drones are bringing spraying to scale.
"The best biostimulant is the one that rides along on a trip the grower was already making."
Takeaway on operations. Prioritise tank-mix compatibility, shelf stability and seed treatment formats. Test products with the fertilisers, crop protection and equipment growers already use.
Lesson 4: Distributors and Advisers Decide Adoption
Most growers buy inputs through retailers, distributors and crop advisers rather than directly from manufacturers. These intermediaries carry thousands of products, and they recommend the ones they understand and trust.
The companies moving first train distributor agronomists, give them trial data for their own region and build programmes that bundle biostimulants with fertiliser and crop protection. SRI's research lists rising adoption of precision agriculture technologies as an opportunity, and the advisers who manage those systems are becoming key influencers of which biologicals get used.
Takeaway on channels. Invest in distributor and adviser education, local trial programmes and bundled crop plans. Make it easy for the people who advise growers to recommend the product with confidence.
Lesson 5: Asia Pacific Grows Fastest, Regulation Shapes Entry Everywhere
SRI's research identifies Asia Pacific as the fastest growing region, driven by intensive horticulture, rising input use and government interest in sustainable farming. Europe benefits from a harmonised approval route, while North America is waiting on a federal definition.
The companies moving first adapt their go-to-market to each regulatory system: CE marking for the EU, state-by-state registration in the United States and national approvals across Asia Pacific. They also adapt products to local crops such as rice, tea and tropical fruit.
The capabilities that decide who captures this demand are specific:
Replicated trial data that proves return per hectare by crop and region.
Microbial pipelines built on strain libraries and formulation science.
Formats that fit existing application timings and equipment.
Distributor and adviser education with bundled crop programmes.
Regulatory teams able to register products market by market.
Companies evaluating these competitive dynamics in greater detail can use SRI's Biostimulants Market analysis to assess product, form, application and crop segments and the positioning of the leading suppliers.
Takeaway on market development. Build regulatory capability for each target market, adapt products to local crops and prioritise Asia Pacific horticulture and row crops for expansion.
Where the Opportunity Is Concentrating
Value is moving toward microbials, stress tolerance and broad-acre crops.
By product type, humic and fulvic acids are the largest segment while microbial biostimulants are the fastest growing.
By form and method, liquid formulations and foliar application lead, while seed treatment and fertigation are growing.
By crop, fruits and vegetables are the largest segment, while turf and ornamentals are growing and row crops offer the largest untapped acreage.
By geography, Asia Pacific is the fastest growing region.
At the Horizon: What to Watch Over the Next Three Years
Regulatory definitions. Progress on a US federal definition and the number of CE-marked products in Europe will show how quickly the category gains a clear identity.
Consolidation. Further acquisitions of microbial and biostimulant specialists by the large crop input companies will show where the majors see value.
Row crop adoption. Use on corn, soybean, wheat and rice through seed treatment will show whether biostimulants move beyond high-value horticulture.
"The next phase of biostimulants will be decided on the row crop acre, where proof has to be strong enough to win millions of hectares."
The Strategic Revenue Opportunity
For biostimulant specialists, the task is to prove return and build distribution. For the large crop input companies, the opportunity is to integrate biologicals into complete crop programmes. For distributors, the priority is agronomic advice that differentiates their offer. For investors, the signal is trial data, microbial pipelines and registrations.
Market intelligence turns these questions into decisions. Segment-level sizing shows where product, form and crop demand is concentrating, competitive analysis shows how suppliers are positioned, and regional analysis shows where regulation and farming systems will pull growth first. This is the path from market signals to strategic insight to revenue impact.
Takeaway on revenue. Treat the biostimulants market as four revenue pools: extracts sold into horticulture on quality, microbials sold on nutrient efficiency, seed treatments sold through seed companies at scale, and bundled crop programmes sold through distributors. Each needs its own pricing model.
The Next Leg: Preparing for the Journey Ahead
The defining shift in biostimulants is that they are moving from specialty add-on to mainstream crop input. That changes how they are sold, who recommends them and where they grow. The companies moving first are not the ones with the most product claims; they are the ones proving return, investing in microbials, fitting existing application, educating distributors and building regulatory reach.
The next three years will decide which suppliers become the default biological partners for growers. Decision-makers should invest in trial evidence, build microbial capability and track regulation, consolidation and row crop adoption. Companies evaluating growth opportunities in this market can use Strategic Revenue Insights' Biostimulants Market report to assess market size, competitive dynamics, regional opportunities and strategic growth priorities.
Sources: Strategic Revenue Insights, Biostimulants Market report (2026); Corteva SEC filing (2026); EU Regulation 2019/1009; US Congress.
Frequently Asked Questions
How big is the biostimulants market?
Strategic Revenue Insights estimates the global biostimulants market at USD 4.5 billion in 2025, rising to USD 13.5 billion by 2034 at a 13.00 percent compound annual growth rate. Humic and fulvic acids are the largest product type, and Asia Pacific is the fastest growing region.
What is driving growth in biostimulants?
Demand for sustainable farming, the need to protect crop yields as climate stress increases, growing farmer acceptance and government initiatives are the main drivers. Tighter rules on synthetic inputs and clearer regulation, such as the EU Fertilising Products Regulation, are also helping the category move into mainstream crop plans.
Which biostimulant segments are growing fastest?
Microbial biostimulants are the fastest growing product type, according to Strategic Revenue Insights. Liquid formulations and foliar application are the most widely used, seed treatment and fertigation are growing, and fruits and vegetables are the largest crop segment while row crops offer the largest untapped acreage.
What are the main challenges for biostimulant suppliers?
The main challenges are the lack of standardised regulations, competition from conventional agrochemicals and limited farmer understanding of how to apply biostimulants and what they return. Suppliers that invest in replicated field trials and distributor education are best placed to overcome these barriers.
About the authors: This article was prepared by the Strategic Revenue Insights research team, which combines market intelligence, competitive analysis and strategic advisory for growth-stage, mid-market and enterprise organisations across the agriculture sector. Sector analyst: Sandeepa Kulkarni, Research Analyst. Our market estimates combine primary research (interviews, surveys and expert panels) with secondary data (industry reports, databases and public disclosures); read more about how Strategic Revenue Insights works. To discuss this market with our analysts, contact our team.
Comments